Medtronic recalls pH monitoring capsule linked to 184 serious injuries

◆ ◆ The Wire takeaway

Medical device founders in diagnostics must brace for heightened scrutiny and recall risks as Medtronic’s repeat airways obstruction fault shows regulators’ tolerance is low. You need swift risk assessments and alternative product strategies to avoid costly disruptions.